Axim Biotechnologies Inc (AXIM)

[Devolution]

The next big milestone event is the 10-Q, due out in 2 days (11/15/22), or if delayed one week as has been customary, then 11/22/22.

I think a lot of the questions we have been asking should be addressed within that report (what convertible loans are still outstanding?, how much was the 6 month advance payment?, what is the status of CLIA wavers?, etc.).

This 10-Q should mark the beginning of a new era for AXIM, one in which it definitively moves out of just being an R&D company and into a revenue generating entity.

I'm not expecting a jaw dropping report, but I am anticipating that there should be some notable details for Axim shareholders to discuss.

Godspeed.